These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 27241313)

  • 41. CD39 positive regulatory T cell frequency as a biomarker of treatment response to methotrexate in rheumatoid arthritis.
    Gupta V; Katiyar S; Singh A; Misra R; Aggarwal A
    Int J Rheum Dis; 2018 Aug; 21(8):1548-1556. PubMed ID: 30146748
    [TBL] [Abstract][Full Text] [Related]  

  • 42. CD4+ FOXP3+ Regulatory T Cells Exhibit Impaired Ability to Suppress Effector T Cell Proliferation in Patients with Turner Syndrome.
    Lee YA; Kim HR; Lee JS; Jung HW; Kim HY; Lee GM; Lee J; Sim JH; Oh SJ; Chung DH; Shin CH; Yang SW
    PLoS One; 2015; 10(12):e0144549. PubMed ID: 26709833
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Isolation strategies of regulatory T cells for clinical trials: phenotype, function, stability, and expansion capacity.
    Ukena SN; Höpting M; Velaga S; Ivanyi P; Grosse J; Baron U; Ganser A; Franzke A
    Exp Hematol; 2011 Dec; 39(12):1152-60. PubMed ID: 21864487
    [TBL] [Abstract][Full Text] [Related]  

  • 44. HSP70 enhances immunosuppressive function of CD4(+)CD25(+)FoxP3(+) T regulatory cells and cytotoxicity in CD4(+)CD25(-) T cells.
    Wachstein J; Tischer S; Figueiredo C; Limbourg A; Falk C; Immenschuh S; Blasczyk R; Eiz-Vesper B
    PLoS One; 2012; 7(12):e51747. PubMed ID: 23300563
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical Remission of Sight-Threatening Non-Infectious Uveitis Is Characterized by an Upregulation of Peripheral T-Regulatory Cell Polarized Towards T-bet and TIGIT.
    Gilbert RM; Zhang X; Sampson RD; Ehrenstein MR; Nguyen DX; Chaudhry M; Mein C; Mahmud N; Galatowicz G; Tomkins-Netzer O; Calder VL; Lightman S
    Front Immunol; 2018; 9():907. PubMed ID: 29774027
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Increased apoptosis induction in CD4+ CD25+ Foxp3+ T cells contributes to enhanced disease activity in patients with rheumatoid arthritis through IL-10 regulation.
    Li N; Ma T; Han J; Zhou J; Wang J; Zhang J; Zheng S
    Eur Rev Med Pharmacol Sci; 2014; 18(1):78-85. PubMed ID: 24452947
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Reduced frequency and functional defects of CD4
    Luo L; Zeng X; Huang Z; Luo S; Qin L; Li S
    Reprod Biol Endocrinol; 2020 Jun; 18(1):62. PubMed ID: 32522204
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Polymorphism of Foxp3 gene affects the frequency of regulatory T cells and disease activity in patients with rheumatoid arthritis in Iranian population.
    Hashemi V; Farrokhi AS; Tanomand A; Babaloo Z; Hojjat-Farsangi M; Anvari E; Tahoori MT; Ezzeddini R; Hosseini A; Gharibi T; Ghalamfarsa G; Jadidi-Niaragh F
    Immunol Lett; 2018 Dec; 204():16-22. PubMed ID: 30292536
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Autoantigen BiP-Derived HLA-DR4 Epitopes Differentially Recognized by Effector and Regulatory T Cells in Rheumatoid Arthritis.
    Shoda H; Fujio K; Sakurai K; Ishigaki K; Nagafuchi Y; Shibuya M; Sumitomo S; Okamura T; Yamamoto K
    Arthritis Rheumatol; 2015 May; 67(5):1171-81. PubMed ID: 25778936
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Rapamycin promotes the enrichment of CD4(+)CD25(hi)FoxP3(+) T regulatory cells from naïve CD4(+) T cells of baboon that suppress antiporcine xenogenic response in vitro.
    Singh AK; Horvath KA; Mohiuddin MM
    Transplant Proc; 2009; 41(1):418-21. PubMed ID: 19249569
    [TBL] [Abstract][Full Text] [Related]  

  • 51. IL-2-Anti-IL-2 Monoclonal Antibody Immune Complexes Inhibit Collagen-Induced Arthritis by Augmenting Regulatory T Cell Functions.
    Yokoyama Y; Iwasaki T; Kitano S; Satake A; Nomura S; Furukawa T; Matsui K; Sano H
    J Immunol; 2018 Oct; 201(7):1899-1906. PubMed ID: 30143591
    [TBL] [Abstract][Full Text] [Related]  

  • 52. An Arthritis-Suppressive and Treg Cell-Inducing CD4+ T Cell Epitope Is Functional in the Context of HLA-Restricted T Cell Responses.
    de Wolf C; van der Zee R; den Braber I; Glant T; Maillère B; Favry E; van Lummel M; Koning F; Hoek A; Ludwig I; van Eden W; Broere F
    Arthritis Rheumatol; 2016 Mar; 68(3):639-47. PubMed ID: 26414917
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pathogenic Transdifferentiation of Th17 Cells Contribute to Perpetuation of Rheumatoid Arthritis during Anti-TNF Treatment.
    Andersson KM; Cavallini NF; Hu D; Brisslert M; Cialic R; Valadi H; Erlandsson MC; Silfverswärd S; Pullerits R; Kuchroo VK; Weiner HL; Bokarewa MI
    Mol Med; 2015 Jun; 21(1):536-43. PubMed ID: 26062018
    [TBL] [Abstract][Full Text] [Related]  

  • 54. In vivo action of IL-27: reciprocal regulation of Th17 and Treg cells in collagen-induced arthritis.
    Moon SJ; Park JS; Heo YJ; Kang CM; Kim EK; Lim MA; Ryu JG; Park SJ; Park KS; Sung YC; Park SH; Kim HY; Min JK; Cho ML
    Exp Mol Med; 2013 Oct; 45(10):e46. PubMed ID: 24091748
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Rapamycin, unlike cyclosporine A, enhances suppressive functions of in vitro-induced CD4+CD25+ Tregs.
    Bocian K; Borysowski J; Wierzbicki P; Wyzgal J; Klosowska D; Bialoszewska A; Paczek L; Górski A; Korczak-Kowalska G
    Nephrol Dial Transplant; 2010 Mar; 25(3):710-7. PubMed ID: 19903662
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Low-dose IL-2 expands CD4
    Li Y; Liu X; Wang W; Wang S; Zhang J; Jiang S; Wang Y; Li L; Li J; Zhang Y; Huang H
    Ren Fail; 2018 Nov; 40(1):280-288. PubMed ID: 29619880
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effector Functions of CD4+ T Cells at the Site of Local Autoimmune Inflammation-Lessons From Rheumatoid Arthritis.
    Chemin K; Gerstner C; Malmström V
    Front Immunol; 2019; 10():353. PubMed ID: 30915067
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Compromised CD4+ CD25(high) regulatory T-cell function in patients with relapsing-remitting multiple sclerosis is correlated with a reduced frequency of FOXP3-positive cells and reduced FOXP3 expression at the single-cell level.
    Venken K; Hellings N; Thewissen M; Somers V; Hensen K; Rummens JL; Medaer R; Hupperts R; Stinissen P
    Immunology; 2008 Jan; 123(1):79-89. PubMed ID: 17897326
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Low-dose IL-2 improved clinical symptoms by restoring reduced regulatory T cells in patients with refractory rheumatoid arthritis: A randomized controlled trial.
    Wang J; Zhang SX; Chang JS; Cheng T; Jiang XJ; Su QY; Zhang JQ; Luo J; Li XF
    Front Immunol; 2022; 13():947341. PubMed ID: 36524114
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Defects in IL-2R signaling contribute to diminished maintenance of FOXP3 expression in CD4(+)CD25(+) regulatory T-cells of type 1 diabetic subjects.
    Long SA; Cerosaletti K; Bollyky PL; Tatum M; Shilling H; Zhang S; Zhang ZY; Pihoker C; Sanda S; Greenbaum C; Buckner JH
    Diabetes; 2010 Feb; 59(2):407-15. PubMed ID: 19875613
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.